|
Michael Narachi, has been a director since November 2006. Mr. Narachi has served as Chairman of the Board of Naryx Pharma, Inc. since August 2004. In 2003, Mr. Narachi retired as an officer and Vice President of Amgen Inc., where he served as General Manager of Amgen's Anemia Business from 1999 to 2003. Mr. Narachi joined Amgen in 1984 and held various positions throughout the organization including: Product Development Team Leader for NEUPOGEN® Director of Clinical Operations in Thousand Oaks, CA and Cambridge, UK; VP of Development and Representative Director for Amgen Japan; Head of Corporate Strategic Planning; Chief Operations Officer of Amgen BioPharma; and VP, Licensing and Business Development. Mr. Narachi received a BS and MA degree in Molecular Genetics from the University of California at Davis in 1984. He received an MBA from the Anderson Graduate School of Management at University of California, Los Angeles. | 